Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis

Abstract

Devic's neuromyelitis optica (NMO) associates optic neuritis and myelopathy without other neurological signs. Many patients with NMO may be diagnosed as having multiple sclerosis (MS). However, there have been no previous studies comparing these two patho logies and it is still unclear if NMO is a separate entity or a subtype of MS. In the present study, we compared a series of NMO patients with a series of MS patients for whom optic neuritis or myelopathy was the presenting symptom, in order to determine the place of NMO in the spectrum of MS. We retrospectively studied 30 patients diagnosed with NMO and we compared these patients with 50 consecutive MS cases revealed by optic neuritis or acute myelopathy. MS patients were only included if a relapse occurred demonstrating time and space dissemination. We compared the two groups in terms of clinical presentatio n, laboratory findings (MRI and C SF) and clinical outcome. NMO patients were older and more frequently women than MS patients but the difference was not significant. C SF and MRI data were clearly different: oligoclonal bands (O C B) were found in 23% of NMO cases and 88% of MS (P B/0.001), abnormal brain MRI data were observed in 10% of NMO cases and 66% of MS (P B/0.001) and a large spinal cord lesion was observed in 67% of NMO cases and 7.4% of MS cases (P B/0.001). C linical outcome was evaluated as more severe in the NMO group (P B/0.001). O n the basis of clinical data, all NMO patients but three had dissemination in time and space. When we included MRI parameters, only two of the NMO patients met criteria for MS and one of the MS patients met criteria for NMO. O ur study demonstrates that NMO and MS should be considered as two different entities. The respective criteria for NMO and MS were able to distinguish these two patho logies but only when MRI data were applied. This finding could have implications for future therapeutic trials.

Keywords

comparative Devic's neuromyelitis optica multiple sclerosis myelopathy

Get full access to this article

View all access options for this article.

References

McAlpine D. Familial neuromyelitis optica: its occurrence in identical twins . Brain 1938; 61: 430-448 .

Leys D , Petit H , Block AM , Docx B , Basin B , Hache JC. Neuromyélite optique de Devic. Quatre cas . Rev Neurol 1987; 143: 722-728 .

Mandler RN , Davis LE , Jeffery DR , Kornfeld M. Devic’s neuromyelitis optica: a clinicopathologicalstudy of 8 patients . Ann Neurol 1993; 34: 162-168 .

O’Riordan JI , Gallagher HL , Thompson AJ , Howard RS , Kingsley DP , Thompson EJ et al. Clinical, CSF and MRI findings in Devic’s neuromyelitis optica . J Neurol Neurosurg Psychiatry 1996; 60: 382-387 .

Wingerchuck DM , Hogancamp WF , O’Brien PC , Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome) . Neurology 1999; 53: 1107-1114 .

de Seze J , Stojkovic T , Ferriby D , Gauvrit JY , Montagne C , Mounier-Vehier F et al. Devic’s neuromyelitis optica: clinical, laboratory, MRI and outcome profile . J Neurol Sci 2002; 197: 57-61 .

Giorgi D , Balacco GC , Bonomo L. The association of optic neuropathy with transverse myelitis in systemic lupus erythematosus . Rheumatology 1999; 32: 191-192 .

Bonnet F , Mercie P , Morlat P , Hocke C , Vergnes C , Ellie E et al. Devic’s neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus . Lupus 1999; 8: 244-247 .

Tesar JT , McMillan V , Molina R , Armstrong J. Optic neuropathy and central nervous system disease associated with primary Sjögren’s syndrome . Am J Med 1992; 92: 686-692 .

10.

de Seze J , Stojkovic T , Hachulla E , Breteau G , Michon-Pasturel U , Mounier-Vehier F et al. Myélopathies et syndrome de Gougerot-Sjögren: étude clinique, radiologique et profil évolutif . Rev Neurol 2001; 157: 669-678 .

11.

Hutchinson D , Solomon T , Moots RJ. Devic’s neuromyelitis optica: a primary autoimmune disease ? Rheumatology 2000; 39: 215-216 .

12.

Barkhof F , Filippi M , Miller DH , Scheltens P , Campi A , Polman CH et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis . Brain 1997; 120: 2059-2069 .

13.

Poser CM , Paty DW , Scheinberg L , McDonald WI , Davis FA , Ebers GC et al. New diagnostic criteria for mutiple sclerosis: guidelines for research protocols . Ann Neurol 1983; 13: 227-231 .

14.

McDonald WI , Compston A , Edan G , Goodkin D , Hartung HP , Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis . Ann Neurol 2001; 50: 121-127 .

15.

Kurtzke J. Rating neurologic impairment in multiple sclerosis . Neurology 1983; 33: 1444-1452 .

16.

Weinshenker BG , Bass B , Rice GP , Noseworthy J , Carriere W , Baskerville J et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability . Brain 1989; 112: 133-146 .

17.

Piccolo G , Franciotta DM , Carnana C , Bergamaschi R , Banfi P , Sandrini G et al. Devic’s neuromyelitis optica: long-term follow-up and serial CSF findings in two cases . J Neurol 1990; 237: 262-264 .

18.

Fazekas F , Offenbacher H , Schmidt R. MRI of neuromyelitis optica: evidence for a distinct entity . J Neurol Neurosurg Psychiatry 1994; 59: 1140-1142 .

19.

Bashir K , Whitaker JN. Importance of paraclinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI . Mult Scler 2000; 6: 312-316 .

20.

Paolino E , Fainardi E , Ruppi P , Tola MR , Govoni V , Casetta I et al. A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis . J Neurol Neurosug Psychiatry 1996; 60: 572-575 .

21.

Lunding J , Midgard R , Vedeler CA. Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focussing, agarose gel electrophoresis and IgG index . Acta Neurol Scand 2000; 102: 322-325 .

22.

McLean BN , Luxton RW , Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid in multiple sclerosis and the log IgG-index . Brain 1990; 113: 1269-1289 .

23.

Filippi M , Rocca MA , Moiola L , Martinelli V , Ghezzi A , Capra R et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica . Neurology 1999; 53: 1705-1710 .

24.

de Seze J , Stojkovic T , Breteau G , Lucas C , Michon-Pasturel U , Gauvrit JY , Hachulla E et al. Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases . Brain 2001; 124: 1509-1521 .

25.

Vernant JC , Cabre P , Smadja D , Merle H , Caubarrere I , Mikol J et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome . Neurology 1997; 48: 58-64 .

26.

Mandler RN , Dencoff JD , Midani F , Ford CC , Ahmed W , Rosenberg GA. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic’s neuromyelitis optica . Brain 2001; 124: 493-498 .

27.

Lucchinetti CF , Mandler RN , McGavern D , Bruck W , Gleich G , Ransohoff RM et al. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica . Brain 2002; 125: 1450-1461 .

28.

Weinchenker BG , Wingerchuk DM , Lucchinetti CF , Lennon VA. A marker autoantibody discriminates neuromyelitis optica from multiple sclerosis . Neurology 2003; 60: A520-A520 .

29.

Miyazawa R , Hikima A , Takamo Y , Arakawa H , Tomomasa T , Morikawa A. Plasmapheresis in fulminant acute disseminated encephalomyelitis . Brain Dev 2001; 23: 424-426 .

30.

Mandler RN , Ahmed W , Dencoff JE. Devic’s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine . Neurology 1998; 51: 1219-1220 .